STADA Arzneimittel Profile

93.75
USD 0.00  0.00%
93.75Last Month High 93.75 
93.75Trading Day  High 93.75 

STADA Arzneimittel Summary

STADA Arzneimittel Aktiengesellschaft (STDAF) is traded on OTC Market in USA. It is located in Bad Vilbel, and employs 10,872 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.96 B. STADA Arzneimittel Aktiengesellschaft has 62.26 M outstanding shares. STADA ARZNEIMI NA has accumulated about 467.48 M in cash with 408.08 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51.
Check STADA Arzneimittel Probability Of Bankruptcy

Key Fundamentals

STADA Arzneimittel Against Markets

Current Ratings  

STADA Arzneimittel 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 39% 
STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. more
NameSTADA Arzneimittel Aktiengesellschaft
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressBad Vilbel,
ExchangeOTC Market
BenchmarkDOW
Websitewww.stada.de
Contact Number49 6101 6030
CurrencyUSD - US Dollar

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Management

STADA Arzneimittel Corporate Management
Carl Oetker Member of the Supervisory Board
JanNicolas Garbe Member of the Supervisory Board
Dieter Koch Member of the Supervisory Board
Eckhard Brueggemann Member of the Supervisory Board, Ph.D